{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:24:28Z","timestamp":1791321868100,"version":"4.3.1"},"reference-count":29,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic graft-versus-host disease (GVHD) is a major limitation of successful allogeneic hematopoietic stem cell transplantation (HSCT). Extracorporeal photochemotherapy (ECP) has been tested extensively in small cohorts of patients with chronic GVHD. In this study, we retrospectively evaluated 71 patients with severe chronic GVHD treated with ECP. Response rate was 61% (n = 43), and 14 patients had complete responses (CRs). The best responses were observed in skin, liver, oral mucosa, and eye. Factors affecting outcomes were assessed in the less heavily pretreated subgroup (n = 63). Thrombocytopenia was associated with a lower response rate (P = .04), and there was a trend toward a higher response rate in de novo chronic GVHD. At 6 months, a total of 27 (69%) of 39 patients who were alive continued to have a sustained response (CR 4 [10%] of 39, and partial response [PR] 23 [59%] of 39). The cumulative incidence of steroid discontinuation at 1 year was 22%. The overall survival since initiation of therapy was 53% at 1 year. Response to ECP and platelet count at initiation of therapy were the strongest predictors of nonrelapse mortality (NRM) on univariate analysis. Objective responses were observed in a substantial number of patients with both skin and visceral chronic GVHD failing corticosteroids and other immunosuppression.<\/jats:p>","DOI":"10.1182\/blood-2005-09-3907","type":"journal-article","created":{"date-parts":[[2005,12,20]],"date-time":"2005-12-20T21:23:14Z","timestamp":1135113794000},"page":"3074-3080","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":238,"title":["Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD"],"prefix":"10.1182","volume":"107","author":[{"given":"Daniel R.","family":"Couriel","sequence":"first","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Hosing","sequence":"additional","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Saliba","sequence":"additional","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Shpall","sequence":"additional","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Anderlini","sequence":"additional","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Rhodes","sequence":"additional","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Smith","sequence":"additional","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa","family":"Khouri","sequence":"additional","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Giralt","sequence":"additional","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"de Lima","sequence":"additional","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Hsu","sequence":"additional","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhra","family":"Ghosh","sequence":"additional","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Neumann","sequence":"additional","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borje","family":"Andersson","sequence":"additional","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzzafar","family":"Qazilbash","sequence":"additional","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Hymes","sequence":"additional","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Kim","sequence":"additional","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Champlin","sequence":"additional","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Donato","sequence":"additional","affiliation":[{"name":"From the Departments of Blood and Marrow Transplantation, Dermatology, and Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111711591022500_REF1","doi-asserted-by":"crossref","unstructured":"Couriel D, Caldera H, Champlin R, Komanduri K. Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer. 2004;101: 1936-1946.","DOI":"10.1002\/cncr.20613"},{"key":"2019111711591022500_REF2","doi-asserted-by":"crossref","unstructured":"Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2003;9: 215-233.","DOI":"10.1053\/bbmt.2003.50026"},{"key":"2019111711591022500_REF3","doi-asserted-by":"crossref","unstructured":"Socie G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation: Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med. 1999;341: 14-21.","DOI":"10.1056\/NEJM199907013410103"},{"key":"2019111711591022500_REF4","doi-asserted-by":"crossref","unstructured":"Couriel DR, Saliba R, Escalon MP, et al. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol. 2005;130: 409-417.","DOI":"10.1111\/j.1365-2141.2005.05616.x"},{"key":"2019111711591022500_REF5","unstructured":"Demierre MF, Foss FM, Koh HK. Proceedings of the International Consensus Conference on Cutaneous T-cell Lymphoma (CTCL) Treatment Recommendations: Boston, Massachusetts, Oct. 1 and 2, 1994. J Am Acad Dermatol. 1997;36: 460-466."},{"key":"2019111711591022500_REF6","doi-asserted-by":"crossref","unstructured":"Gottlieb SL, Wolfe JT, Fox FE, et al. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution. J Am Acad Dermatol. 1996;35: 946-957.","DOI":"10.1016\/S0190-9622(96)90119-X"},{"key":"2019111711591022500_REF7","doi-asserted-by":"crossref","unstructured":"Evans AV, Wood BP, Scarisbrick JJ, et al. Extra-corporeal photopheresis in Sezary syndrome: hematologic parameters as predictors of response. Blood. 2001;98: 1298-1301.","DOI":"10.1182\/blood.V98.5.1298"},{"key":"2019111711591022500_REF8","doi-asserted-by":"crossref","unstructured":"Duvic M, Hester JP, Lemak NA. Photopheresis therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 1996;35: 573-579.","DOI":"10.1016\/S0190-9622(96)90683-0"},{"key":"2019111711591022500_REF9","doi-asserted-by":"crossref","unstructured":"Heshmati F. Mechanisms of action of extracorporeal photochemotherapy. Transfus Apheresis Sci. 2003;29: 61-70.","DOI":"10.1016\/S1473-0502(03)00103-4"},{"key":"2019111711591022500_REF10","doi-asserted-by":"crossref","unstructured":"Knobler R, Girardi M. Extracorporeal photochemoimmunotherapy in cutaneous T cell lymphomas. Ann N Y Acad Sci. 2001;941: 123-138.","DOI":"10.1111\/j.1749-6632.2001.tb03716.x"},{"key":"2019111711591022500_REF11","doi-asserted-by":"crossref","unstructured":"Greinix HT, Volc-Platzer B, Rabitsch W, et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood. 1998;92: 3098-3104.","DOI":"10.1182\/blood.V92.9.3098"},{"key":"2019111711591022500_REF12","unstructured":"Sniecinski IPP, Dagis A, Smith B. Extracorporeal photopheresis (EP) is effective treatment for chronic refractory graft versus host disease. Blood. 1998;92: 454a. Abstract 1877."},{"key":"2019111711591022500_REF13","doi-asserted-by":"crossref","unstructured":"Child FJ, Ratnavel R, Watkins P, et al. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplant. 1999;23: 881-887.","DOI":"10.1038\/sj.bmt.1701733"},{"key":"2019111711591022500_REF14","doi-asserted-by":"crossref","unstructured":"Salvaneschi L, Perotti C, Zecca M, et al. Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion. 2001;41: 1299-1305.","DOI":"10.1046\/j.1537-2995.2001.41101299.x"},{"key":"2019111711591022500_REF15","doi-asserted-by":"crossref","unstructured":"Apisarnthanarax N, Donato M, Korbling M, et al. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplant. 2003;31: 459-465.","DOI":"10.1038\/sj.bmt.1703871"},{"key":"2019111711591022500_REF16","unstructured":"Abhyankar S, Bishop M. Adjunctive treatment of resistant chronic graft-versus-host disease with extracorporeal photopheresis, using UVADEX Sterile Solution [abstract]. Blood. 1998;92: 454a. Abstract 1876."},{"key":"2019111711591022500_REF17","doi-asserted-by":"crossref","unstructured":"Sullivan KM, Shulman HM, Storb R, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood. 1981;57: 267-276.","DOI":"10.1182\/blood.V57.2.267.bloodjournal572267"},{"key":"2019111711591022500_REF18","doi-asserted-by":"crossref","unstructured":"Kanold J, Paillard C, Halle P, D'Incan M, Bordigoni P, Demeocq F. Extracorporeal photochemotherapy for graft versus host disease in pediatric patients. Transfus Apheresis Sci. 2003;28: 71-80.","DOI":"10.1016\/S1473-0502(02)00102-7"},{"key":"2019111711591022500_REF19","doi-asserted-by":"crossref","unstructured":"Halle P, Paillard C, D'Incan M, et al. Successful extracorporeal photochemotherapy for chronic graft-versus-host disease in pediatric patients. J Hematother Stem Cell Res. 2002;11: 501-512.","DOI":"10.1089\/15258160260090960"},{"key":"2019111711591022500_REF20","doi-asserted-by":"crossref","unstructured":"Ullrich SE. Photoinactivation of T-cell function with psoralen and UVA radiation suppresses the induction of experimental murine graft-versus-host disease across major histocompatibility barriers. J Invest Dermatol. 1991;96: 303-308.","DOI":"10.1111\/1523-1747.ep12465134"},{"key":"2019111711591022500_REF21","doi-asserted-by":"crossref","unstructured":"Foss FM, Gorgun G, Miller KB. Extracorporeal photopheresis in chronic graft-versus-host disease. Bone Marrow Transplant. 2002;29: 719-725.","DOI":"10.1038\/sj.bmt.1703529"},{"key":"2019111711591022500_REF22","doi-asserted-by":"crossref","unstructured":"Bladon J, Taylor PC. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients. Br J Haematol. 1999;107: 707-711.","DOI":"10.1046\/j.1365-2141.1999.01773.x"},{"key":"2019111711591022500_REF23","doi-asserted-by":"crossref","unstructured":"Di Renzo M, Rubegni P, Sbano P, et al. ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas\/FasL system and the Bcl-2 protein family. Arch Dermatol Res. 2003;295: 175-182.","DOI":"10.1007\/s00403-003-0415-6"},{"key":"2019111711591022500_REF24","doi-asserted-by":"crossref","unstructured":"Fimiani M, Di Renzo M, Rubegni P. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease. Br J Dermatol. 2004;150: 1055-1060.","DOI":"10.1111\/j.1365-2133.2004.05918.x"},{"key":"2019111711591022500_REF25","doi-asserted-by":"crossref","unstructured":"Gorgun G, Miller KB, Foss FM. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood. 2002;100: 941-947.","DOI":"10.1182\/blood-2002-01-0068"},{"key":"2019111711591022500_REF26","doi-asserted-by":"crossref","unstructured":"Lee S, Dorken B, Schmitt CA. Extracorporeal photopheresis in graft-versus-host disease: ultraviolet radiation mediates T cell senescence in vivo. Transplantation. 2004;78: 484-485.","DOI":"10.1097\/01.TP.0000128835.06220.44"},{"key":"2019111711591022500_REF27","doi-asserted-by":"crossref","unstructured":"Seaton ED, Szydlo RM, Kanfer E, Apperley JF, Russell-Jones R. Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. Blood. 2003;102: 1217-1223.","DOI":"10.1182\/blood-2002-11-3351"},{"key":"2019111711591022500_REF28","doi-asserted-by":"crossref","unstructured":"Craciun LI, Stordeur P, Schandene L, et al. Increased production of interleukin-10 and interleukin-1 receptor antagonist after extracorporeal photochemotherapy in chronic graft-versus-host disease. Transplantation. 2002;74: 995-1000.","DOI":"10.1097\/00007890-200210150-00017"},{"key":"2019111711591022500_REF29","doi-asserted-by":"crossref","unstructured":"Sullivan KM, Witherspoon RP, Storb R, et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood. 1988;72: 555-561.","DOI":"10.1182\/blood.V72.2.555.555"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/8\/3074\/1280465\/zh800806003074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/8\/3074\/1280465\/zh800806003074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T11:59:22Z","timestamp":1573991962000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/107\/8\/3074\/22178\/Extracorporeal-photochemotherapy-for-the-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,15]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,4,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-09-3907","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,15]]}}}